Clinical Trial Detail

NCT ID NCT03454165
Title A Study of BNC105P Combined With Ibrutinib
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dartmouth-Hitchcock Medical Center
Indications

CLL/SLL

chronic lymphocytic leukemia

Therapies

BNC105P + Ibrutinib

Age Groups: senior adult

No variant requirements are available.